[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 24/31, 2002

St John's Wort and Depression

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;288(4):446-449. doi:10.1001/jama.288.4.446

To the Editor: Dr Davidson and colleagues1 report the unlikely finding that neither hypericum nor sertraline was more effective than placebo in improving scores on the Hamilton Depression Rating Scale (HAM-D), which may suggest a flaw in the study design. From Table 1, the "duration of current depression [emphasis added]" was less than 6 months in only 34% of the patients admitted to the trial but 6 to 24 months in 34% and more than 24 months in 32%. These data imply that this group of patients had relatively long-term chronic depression. It is possible that many of these patients were already treatment resistant, which may be responsible for the apparent lack of response to sertraline, a finding that is at variance with the considerable literature on this antidepressant. The same conclusion may also apply to hypericum, for which at least 27 double-blind placebo-controlled trials have demonstrated an antidepressant effect.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×